previously few years, the UK has witnessed a revolution in health-related bodyweight‑reduction treatments — in the introduction of semaglutide (Wegovy®) for the developing popularity of tirzepatide (Mounjaro®). Now, One more name is drawing attention in both of those scientific and general public